title: [Medical applications of ozone for the rehabilitation of the patients presenting with chronic bronchitis and arterial hypertension].
abstract: Of paramount importance at the stage of rehabilitative treatment of the patients presenting with combined cardiorespiratory pathology are therapeutic measures aimed at eliminating the principal components of pathogenesis of a given disease and correcting the concomitant immunometabolic disturbances. Our investigations have demonstrated that ozone therapy given to the patients with chronic bronchitis and hypertension produces lipid-lowering, hypoglycemic and fibrinolytic effects. Its combination with anti-hypoxic treatment helps to normalize the functioning capabilities of all organs and systems of the body. Immunomodulatory effects of ozone therapy is attributable to the disintoxicative and anti-hypoxic actions of medical ozone as well as activation of the "lipid peroxidation--antioxidant protection" system.
authors.forename: E V
authors.initials: EV
authors.lastname: Khmeleva
authors.forename: T I
authors.initials: TI
authors.lastname: Vitkina
authors.forename: M V
authors.initials: MV
authors.lastname: Antoniuk
authors.forename: A D
authors.initials: AD
authors.lastname: Novgorodtsev
mesh_terms: D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000378:metabolism; D029481:Bronchitis, Chronic / Q000097:blood / Q000534:rehabilitation*; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000534:rehabilitation*; D015227:Lipid Peroxidation / Q000187:drug effects; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D010083:Oxidants, Photochemical / Q000008:administration & dosage*; D010126:Ozone / Q000008:administration & dosage*
chemical_list: D000975:Antioxidants; D008055:Lipids; D010083:Oxidants, Photochemical; D010126:Ozone